Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 96

Report ID: 37688

Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.
In 2018, the global Peptide Based Gastrointestinal Disorders Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Peptide Based Gastrointestinal Disorders Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Peptide Based Gastrointestinal Disorders Therapeutics development in United States, Europe and China.

The key players covered in this study
Shire
Ironwood Pharmaceuticals
Astellas Pharma
Allergan
Takeda Pharmaceutical
...

Market segment by Type, the product can be split into
Teduglutide
Linaclotide
Others

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Peptide Based Gastrointestinal Disorders Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Peptide Based Gastrointestinal Disorders Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Peptide Based Gastrointestinal Disorders Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Teduglutide
1.4.3 Linaclotide
1.4.4 Others
1.5 Market by Application
1.5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Size
2.2 Peptide Based Gastrointestinal Disorders Therapeutics Growth Trends by Regions
2.2.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Regions (2014-2025)
2.2.2 Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Manufacturers
3.1.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players Head office and Area Served
3.3 Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product/Solution/Service
3.4 Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2014-2019)
4.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2014-2019)
5.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in United States
5.3 United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
5.4 United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application

6 Europe
6.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2014-2019)
6.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Europe
6.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
6.4 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application

7 China
7.1 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2014-2019)
7.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in China
7.3 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
7.4 China Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application

8 Japan
8.1 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2014-2019)
8.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Japan
8.3 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
8.4 Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2014-2019)
9.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
9.4 Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application

10 India
10.1 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2014-2019)
10.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in India
10.3 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
10.4 India Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2014-2019)
11.2 Peptide Based Gastrointestinal Disorders Therapeutics Key Players in Central & South America
11.3 Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
11.4 Central & South America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application

12 International Players Profiles
12.1 Shire
12.1.1 Shire Company Details
12.1.2 Company Description and Business Overview
12.1.3 Peptide Based Gastrointestinal Disorders Therapeutics Introduction
12.1.4 Shire Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)
12.1.5 Shire Recent Development
12.2 Ironwood Pharmaceuticals
12.2.1 Ironwood Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Peptide Based Gastrointestinal Disorders Therapeutics Introduction
12.2.4 Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)
12.2.5 Ironwood Pharmaceuticals Recent Development
12.3 Astellas Pharma
12.3.1 Astellas Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Peptide Based Gastrointestinal Disorders Therapeutics Introduction
12.3.4 Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)
12.3.5 Astellas Pharma Recent Development
12.4 Allergan
12.4.1 Allergan Company Details
12.4.2 Company Description and Business Overview
12.4.3 Peptide Based Gastrointestinal Disorders Therapeutics Introduction
12.4.4 Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)
12.4.5 Allergan Recent Development
12.5 Takeda Pharmaceutical
12.5.1 Takeda Pharmaceutical Company Details
12.5.2 Company Description and Business Overview
12.5.3 Peptide Based Gastrointestinal Disorders Therapeutics Introduction
12.5.4 Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2014-2019)
12.5.5 Takeda Pharmaceutical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details